Citalopram reduces endotoxin-induced fatigue

Brain, Behavior, and Immunity

Volumn 25, Issue 2, 2011, Pages 256-259

  Hannestad, Jonas ^a   DellaGioia, Nicole ^a   Ortiz, Nyrma ^a   Pittman, Brian ^a   Bhagwagar, Zubin ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressant; Citalopram; Cytokines; Depression; Endotoxin; Fatigue

Indexed keywords

CITALOPRAM; ENDOTOXIN; INTERLEUKIN 6; PLACEBO; TUMOR NECROSIS FACTOR;

ADULT; ANHEDONIA; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; CROSSOVER PROCEDURE; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; FEMALE; HUMAN; LASSITUDE; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NAUSEA AND VOMITING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VISUAL ANALOG SCALE;

ADULT; ANXIETY; BEHAVIOR; CITALOPRAM; CYTOKINES; DEPRESSION; DOUBLE-BLIND METHOD; ENDOTOXINS; FATIGUE; FEMALE; HUMANS; INTERPERSONAL RELATIONS; MALE; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SOCIAL BEHAVIOR;

EID: 78651434624     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.10.013     Document Type: Article

References (25)

1. Bull S.J., Huezo-Diaz P., Binder E.B., Cubells J.F., Ranjith G., Maddock C., et al. Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Mol. Psychiatry 2009, 14(12):1095-1104.
2. Capuron L., Fornwalt F.B., Knight B.T., Harvey P.D., Ninan P.T., Miller A.H. Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?. J. Affect. Disorders 2009, 119(1-3):181-185.
3. Capuron L., Neurauter G., Musselman D.L., Lawson D.H., Nemeroff C.B., Fuchs D., et al. Interferon-alpha-induced changes in tryptophan metabolism relationship to depression and paroxetine treatment. Biol. Psychiatry 2003, 54(9):906-914.
4. Chung Y.C., Kim S.R., Jin B.K. Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease. J. Immunol. 2010, 185(2):1230-1237.
5. de Mendonca Lima C.A., Baumann P., Brawand-Amey M., Brogli C., Jacquet S., Cochard N., et al. Effect of age and gender on citalopram and desmethylcitalopram steady-state plasma concentrations in adults and elderly depressed patients. Prog. Neuro-psychoph. 2005, 29(6):952-956.
6. DellaGioia N., Hannestad J. A critical review of human endotoxin administration as an experimental paradigm of depression. Neurosci. Biobehav. R. 2010, 34(1):130-143.
7. DeLuca J., Genova H.M., Capili E.J., Wylie G.R. Functional neuroimaging of fatigue. Phys. Med. Rehabil. Clin. N. Am. 2009, 20(2):325-337.
8. Demyttenaere K., De Fruyt J. Getting what you ask for: on the selectivity of depression rating scales. Psychother. Psychosom. 2003, 72(2):61-70.
9. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., et al. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67(5):446-457.
10. Eisenberger N.I., Inagaki T.K., Mashal N.M., Irwin M.R. Inflammation and social experience: an inflammatory challenge induces feelings of social disconnection in addition to depressed mood. Brain Behav Immun 2010, 24(4):558-563.
11. Eisenberger N.I., Inagaki T.K., Rameson L.T., Mashal N.M., Irwin M.R. An fMRI study of cytokine-induced depressed mood and social pain: the role of sex differences. Neuroimage 2009, 47(3):881-890.
12. Kraus M.R., Schafer A., Schottker K., Keicher C., Weissbrich B., Hofbauer I., et al. Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study. Gut 2008, 57(4):531-536.
13. Lotrich F.E., Ferrell R.E., Rabinovitz M., Pollock B.G. Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism. Biol. Psychiatry 2009, 65(4):344-348.
14. McNally L., Bhagwagar Z., Hannestad J. Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr. 2008, 13(6):501-510.
15. Meeusen R., Watson P., Hasegawa H., Roelands B., Piacentini M.F. Central fatigue: the serotonin hypothesis and beyond. Sports Med. 2006, 36(10):881-909.
16. Michie H.R., Manogue K.R., Spriggs D.R., Revhaug A., O'Dwyer S., Dinarello C.A., et al. Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 1988, 318(23):1481-1486.
17. Muller N., Schwarz M.J. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol. Psychiatry 2007, 12(11):988-1000.
18. Nutt D., Demyttenaere K., Janka Z., Aarre T., Bourin M., Canonico P.L., et al. The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. J. Psychopharmacol. 2007, 21(5):461-471.
19. O'Connor J.C., Lawson M.A., Andre C., Moreau M., Lestage J., Castanon N., et al. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol. Psychiatry 2009, 14(5):511-522.
20. Raison C.L., Dantzer R., Kelley K.W., Lawson M.A., Woolwine B.J., Vogt G., et al. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol. Psychiatry 2010, 15(4):393-403.
21. Raison C.L., Woolwine B.J., Demetrashvili M.F., Borisov A.S., Weinreib R., Staab J.P., et al. Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C. Aliment. Pharm. Therap. 2007, 25(10):1163-1174.
22. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry 2001, 58(5):445-452.
23. Roumestan C., Michel A., Bichon F., Portet K., Detoc M., Henriquet C., et al. Anti-inflammatory properties of desipramine and fluoxetine. Respir. Res. 2007, 8:35.
24. Suffredini A.F., Hochstein H.D., McMahon F.G. Dose-related inflammatory effects of intravenous endotoxin in humans: evaluation of a new clinical lot of Escherichia coli O:113 endotoxin. J. Infect. Dis. 1999, 179(5):1278-1282.
25. Xia Z., DePierre J.W., Nassberger L. Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology 1996, 34(1):27-37.